Oral antidiabetic agents

Chiasson, Prof. J.-L., Montréal, Canada
Glucose lowering interventions in diabetes and CVD - lessons from outcome studies(Archiv)
18-Oct-09
Josse, Prof. R., Toronto, Canada
Acarbose - safe and effective glycaemic control with cardiovascular benefits(Archiv)
18-Oct-09
Schnell, Prof. O., Munich, Germany
Recent guideline recommendations for managing pre- and established diabetes and CVD(Archiv)
18-Oct-09
Schwarz, Prof. P., Dresden, Germany
Education and intervention programs to prevent diabetes and its complications(Archiv)
18-Oct-09
Chiasson, Prof. J.-L., Montréal, Canada
Acarbose - a safe and effective treatment choice for pre- and established diabetes with cardiovascular benefits(Archiv)
01-Jun-08
Holman, Prof. R., Oxford, United Kingdom
The new Acarbose Cardiovascular Evaluation (ACE) outcome trial - secondary prevention of CVD in Prediabetes(Archiv)
01-Jun-08
Cefalu, Dr. W., Pennington, United States
Beyond Oral Therapy: Which Insulin to start with?(Archiv)
17-Oct-07
Wolffenbuttel, Prof. B., Groningen, Netherlands
Beyond Oral Therapy: Which Insulin to start with?(Archiv)
17-Oct-07
Standl, Prof. E., Munich, Germany
New Coaching Techniques(Archiv)
18-Sep-07
Vilsbøll, Dr. T., Copenhagen, Denmark
Incretins - The Body´s Own Defensive Player(Archiv)
18-Sep-07
Nauck, Prof. M. A., Bad Lauterberg, Germany
Sitagliptin - The New Player(Archiv)
18-Sep-07
Scott, Dr. R., New Zealand
The Changing Landscape In Type 2 Diabetes Management(Archiv)
17-Sep-07
Deacon, Dr. C., Denmark
Integrating Incretin-Based Therapies In The Treatment Of Type 2 Diabetes(Archiv)
17-Sep-07
Nauck, Prof. M. A., Bad Lauterberg, Germany
Archieving Therapeutic Goals With Sitagliptin(Archiv)
17-Sep-07
Rydén, Prof. L., Stockholm, Sweden
The Deadly Duo Dysglycemia And CVD - Recommendations From Current Guidelines(Archiv)
17-Sep-07
Standl, Prof. E., Munich, Germany
Treating And Preventing Dysglycemia And CVD - Understanding The Challenge(Archiv)
17-Sep-07
Chiasson, Prof. J.-L., Montréal, Canada
Acarbose – a proven role in prediabetes and beyond(Archiv)
03-Dec-06
Del Prato, Prof. S., Pisa, Italy
Realising the benefits of acarbose across the disease continuum(Archiv)
05-Sep-04
Haffner, Prof. S., San Antonio, United States
Acarbose - a first-line therapy to break the CVD connection(Archiv)
05-Sep-04